INVO BioScience, Inc.(INVO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

INVO INVO BioScience, Inc.

Post-Market Trading 05-21 16:31:13 EDT

0.9143

-0.0147

-1.58%

盘后0.9185

+0.0042+0.46%

16:29 EDT

High0.9601	Low0.9136	Vol61.95K
Open0.9200	D1 Closing0.9290	Amplitude5.01%
Mkt Cap3.47M	Tradable Cap3.45M	Total Shares3.80M
T/O57.60K	T/O Rate1.64%	Tradable Shares3.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"INVO","market":"US","secType":"STK","nameCN":"INVO BioScience, Inc.","latestPrice":0.9143,"timestamp":1716321600000,"preClose":0.929,"halted":0,"volume":61947,"hourTrading":{"tag":"盘后","latestPrice":0.9185,"preClose":0.9143,"latestTime":"16:29 EDT","volume":248,"amount":226.78840128000002,"timestamp":1716323344482},"delay":0,"floatShares":3769000,"shares":3797100,"eps":-2.999095,"marketStatus":"Post-Market Trading","change":-0.0147,"latestTime":"05-21 16:31:13 EDT","open":0.92,"high":0.9601,"low":0.9136,"amount":57602.689933,"amplitude":0.050054,"askPrice":0.97,"askSize":100,"bidPrice":0.9142,"bidSize":269,"shortable":3,"etf":0,"ttmEps":-2.999095,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1716336000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.929,"preHourTrading":{"tag":"盘前","latestPrice":0.92,"preClose":0.929,"latestTime":"09:16 EDT","volume":56,"amount":51.65550152,"timestamp":1716297403891},"postHourTrading":{"tag":"盘后","latestPrice":0.9185,"preClose":0.9143,"latestTime":"16:29 EDT","volume":248,"amount":226.78840128000002,"timestamp":1716323344482},"volumeRatio":0.271363},"requestUrl":"/m/hq/s/INVO","defaultTab":"news","newsList":[{"id":"2435032046","title":"GoodRx Holdings, Seelos Therapeutics, Clever Leaves among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2435032046","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435032046?lang=en_us&edition=fundamental","pubTime":"2024-05-16 22:00","pubTimestamp":1715868047,"startTime":"0","endTime":"0","summary":"Gainers: Clever Leaves Holdings  +10%. Nutriband  +13%. GoodRx Holdings  +10%. Celcuity  +9%. INVO Bioscience  +10%.  Losers: 180 Life Sciences  -24%. Omeros Corporation  -22%. Eyenovia  -22%. Inhibikase Therapeutics  -15%. Seelos Therapeutics  -10%.  S&P 500 Health Care Sector -0.29% to 1697.09. Health Care Equipment & Services +0.17% to 1964.83. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is -0.63% to 1392.52.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4107430-goodrx-holdings-seelos-therapeutics-clever-leaves-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2435160886","title":"MGNI, VERV and GWAV among pre-market gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2435160886","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435160886?lang=en_us&edition=fundamental","pubTime":"2024-05-16 21:25","pubTimestamp":1715865925,"startTime":"0","endTime":"0","summary":"Gainers: TSR  +70% on being acquired by Vienna Parent for $13.40 per share. Pineapple Energy  +64%. Crown ElectroKinetics  +56%. Greenwave Technology Solutions  +56%. Jiade  +52%. AST SpaceMobile  +31%. after reporting Q1 results. BM Technologies  +25% after reporting Q1 results.  LM Funding America  +18% after reporting Q1 results. Smart for Life  +23%. Canada Goose Holdings  +14% after reporting Q4 results. My Size  +14% after reporting Q1 results. Gorilla Technology Group  +11%. Corebridge Financial  +11%. GameSquare Holdings  +11% on formation of FaZe Media. Magnite  +11%. INVO Bioscience  +10% after reporting Q1 results. SilverBow Resources  +10% on being acquired by Crescent Energy in $2.1B all-stock deal. ZTO Express  +10% after reporting Q1 results. Lightspeed Commerce  +9% after reporting Q4 results. Expion360  +9%. on announcing new online retail partnership with Tractor Supply Company. GoodRx Holdings  +8% on entering agreement with Kroger for improved prescription pricing. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4107387-mgni-verv-and-gwav-among-pre-market-gainers","is_publish_highlight":false,"gpt_icon":0},{"id":"2435670242","title":"INVO BioScience reports Q1 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2435670242","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435670242?lang=en_us&edition=fundamental","pubTime":"2024-05-16 21:23","pubTimestamp":1715865798,"startTime":"0","endTime":"0","summary":"INVO BioScience press release  (NASDAQ:INVO): Q1 reported net loss was $1.6 million compared to $2.6 million last year.\nRevenue was $1,576,286, an increase of 353% compared to $348,025.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4107383-invo-bioscience-reports-q1-results","is_publish_highlight":false,"gpt_icon":0},{"id":"2435934667","title":"INVO Bioscience Q1 EPS $(0.42), Sales $1.58M Up From $348.02K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2435934667","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2435934667?lang=en_us&edition=fundamental","pubTime":"2024-05-16 04:45","pubTimestamp":1715805901,"startTime":"0","endTime":"0","summary":"INVO Bioscience (NASDAQ:INVO) reported quarterly losses of $(0.42) per share. The company reported $1.58 million in sales this quarter. This is a 352.84 percent increase over sales of $348.02 thousand the same period","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38858730/invo-bioscience-q1-eps-0-42-sales-1-58m-up-from-348-02k-yoy","is_publish_highlight":false,"gpt_icon":0},{"id":"2435625236","title":"INVO Reports Record First Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2435625236","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2435625236?lang=en_us&edition=fundamental","pubTime":"2024-05-15 20:15","pubTimestamp":1715775300,"startTime":"0","endTime":"0","summary":"353% Revenue Growth with improvement in Adjusted EBITDASARASOTA, Fla., May  15, 2024  (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) (\"INVO\" or the \"Company\"), a healthcare services fertilit","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/15/2882917/0/en/INVO-Reports-Record-First-Quarter-2024-Financial-Results.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435637518","title":"APP, MGNX and CYCC among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2435637518","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2435637518?lang=en_us&edition=fundamental","pubTime":"2024-05-14 20:25","pubTimestamp":1715689547,"startTime":"0","endTime":"0","summary":"Losers: Augmedix  -38% reports Q1 results. Inotiv  -35% report fiscal 2024 second Quarter financial results and host conference call on Wednesday, May 15, 2024. Eastside Distilling  -28% after Q1 earnings release. Akoya Biosciences  -22% after Q1 earnings release. Inspire Veterinary Partners  -17%.  INVO Bioscience  -13%. Terran Orbital Corp  -10% after Q1 earnings release. BuzzFeed  -10% after Q1 earnings release. Cyclacel Pharmaceuticals  -9%. TeraWulf  -7% after Q1 earnings release. AGBA Group Holding Limited  -9%. Tevogen Bio Holdings  -7%. Nano Nuclear Energy  -4%. Macrogenics  -6%. AC Immune  -8%. Intuitive Machines  -7% after Q1 earnings release. New Gold  -6% files for mixed shelf offering. AEye  -7%. Lithium Americas Corp  -6% after Q1 earnings release. StoneCo Ltd  -7% after Q1 earnings release. TMC the metals company  -5% after Q1 earnings release. Applovin Corp  -5%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4105739-app-mgnx-and-cycc-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2429928727","title":"SBFM, BPTH and INDO among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2429928727","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429928727?lang=en_us&edition=fundamental","pubTime":"2024-04-22 20:23","pubTimestamp":1713788630,"startTime":"0","endTime":"0","summary":"Losers: Hepion Pharmaceuticals  -38% initiates wind-down activities in Phase 2b ‘ASCEND-NASH’ trial. Top Wealth Group Holding Limited  -17%. Redwoods Acquisition Corp  -13%. Sunshine Biopharma  -12%. MediaCo Holding  -11%. Indonesia Energy Corp Ltd  -11%. Bio-Path Holdings  -9%.  INVO Bioscience  -9%. Li Auto  -7% shares slide after matching Tesla price cuts. Edible Garden  -7%. Mobile health Network Solutions  -3%. Endeavour Silver Corp.  -7% celebrates Milestone: Terronera surpasses 50% construction completion. Zhongchao  -6%. First Majestic Silver Corporation  -6%. Coeur Mining  -6%. Hub Cyber Security Ltd  -6%. Nova Lifestyle  -6%. Harmony Gold Mining Co Ltd  -6%. Pan American Silver Corp  -6%. Vizsla Silver Corp  -6%. AngloGold Ashanti  -6%. MAG Silver Corp.  -5%. Chromocell Therapeutics Corp.  -5%.   More on pre-market losers & stocks.  Bio-Path Holdings Inc.  Q4 2023 Earnings Call Transcript Bio-Path announces $1.2M registered direct offering priced at-the-market Bio-Path shares","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4091863-sbfm-bpth-and-indo-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2428692603","title":"INVO Bioscience Navigates Lease Assignment and Nasdaq Woes","url":"https://stock-news.laohu8.com/highlight/detail?id=2428692603","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2428692603?lang=en_us&edition=fundamental","pubTime":"2024-04-20 05:32","pubTimestamp":1713562372,"startTime":"0","endTime":"0","summary":"INVO Bioscience (INVO) just unveiled an announcement. INVO Bioscience, through its subsidiary INVO Centers, has assigned its Tampa property lease t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/invo-bioscience-navigates-lease-assignment-and-nasdaq-woes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/invo-bioscience-navigates-lease-assignment-and-nasdaq-woes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2428520456","title":"Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2428520456","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2428520456?lang=en_us&edition=fundamental","pubTime":"2024-04-19 22:00","pubTimestamp":1713535225,"startTime":"0","endTime":"0","summary":"Gainers: Zhongchao  +47%. Neurometrix  +19%. Mobile health Network Solutions  +17%. IMAC Holdings  +10%. Predictive Oncology  +10%.  Losers: Sunshine Biopharma  -39%. Nexalin Technology  -12%. BIMI Holdings  -9%. INVO Bioscience  -8%. Allarity Therapeutics  -5%.   S&P 500 Health Care Sector +0.35% to 1619.29. Health Care Equipment & Services +0.62% to 1915.01. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.13% to 1308.25.  More on Health Care Select Sector SPDR  XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March Drug shortages in U.S. at highest level on record since 2001 Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4091509-predictive-oncology-bimi-holdings-imac-holdings-among-healthcare-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2428865542","title":"LI, VERU and MRIN among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2428865542","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2428865542?lang=en_us&edition=fundamental","pubTime":"2024-04-19 20:16","pubTimestamp":1713528980,"startTime":"0","endTime":"0","summary":"Losers: Tritium DCFC Limited  -59%. Nexalin Technology  -29%. Moolec Science  -17%. AGBA Group Holding Limited  -15%. INVO Bioscience  -11%. Iczoom Group  -11%. Sunshine Biopharma  -10% receives health Canada approval for Niopeg, a Biosimilar of Neulasta.  Marin Software  -9%. Veru  -7%. Smith Micro Software  -7%. TH International Ltd.  -7%. Netflix  -6% after Q1 earnings release. Li Auto  -6%.   More on pre-market losers & stocks.  Buy Li Auto's Dip - Electrification Is Here To Stay Li Auto Q4: Crushing Expectations Li Auto Charges Ahead In Fourth Quarter As Slowdown Looms Li Auto is tagged with a higher rating at Macquarie than NIO and XPeng Ohio Senator Sherrod Brown calls for ban on the sale of Chinese-made EVs in the U.S.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4091418-li-veru-and-mrin-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2428872516","title":"Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2428872516","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2428872516?lang=en_us&edition=fundamental","pubTime":"2024-04-18 23:32","pubTimestamp":1713454370,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/04/38318101/why-las-vegas-sands-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-","is_publish_highlight":false,"gpt_icon":0},{"id":"2428767598","title":"INVO, EZGO and WISA among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2428767598","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2428767598?lang=en_us&edition=fundamental","pubTime":"2024-04-18 20:15","pubTimestamp":1713442507,"startTime":"0","endTime":"0","summary":"Losers: Lithium Americas Corp  -24% on plans for 55M-share offering. NRX Pharmaceuticals  -22% announces proposed underwritten public offering of common stock. Canaan  -22% files for $300M mixed shelf offering. Iczoom Group  -12%. INVO Bioscience  -12%. BYND Cannasoft Enterprises  -11%.  WiSA Technologies  -9%. Infosys Ltd  -8% reports mixed Q4 results. EZGO Technologies Ltd  -6%. Rentokil Initial Plc.  -7%. TRACON Pharmaceuticals  -6%. Indonesia Energy Corp Ltd  -6%. Organovo Holdings  -5%.   More on Pre-market losers & stocks.  EZGO Technologies partners with Woteam New Energy to explore Southeast Asian market WiSA jumps on announcing fourth HDTV/PTV license with major TV brand Financial information for EZGO Technologies  Seeking Alpha’s Quant Rating on INVO BioScience Historical earnings data for INVO BioScience","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4090933-invo-ezgo-and-wisa-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2428713349","title":"Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2428713349","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2428713349?lang=en_us&edition=fundamental","pubTime":"2024-04-17 22:07","pubTimestamp":1713362873,"startTime":"0","endTime":"0","summary":"U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday.\n\nFollowing the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ rose 0.24% to 15,903.38. The S&amp;P 500 also rose, gaining, 0.40% to 5,071.74.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/04/38293458/dow-surges-200-points-abbott-laboratories-posts-upbeat-earnings","is_publish_highlight":false,"gpt_icon":1},{"id":"2428894385","title":"INVO BioScience reports Q4 results","url":"https://stock-news.laohu8.com/highlight/detail?id=2428894385","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2428894385?lang=en_us&edition=fundamental","pubTime":"2024-04-17 05:17","pubTimestamp":1713302245,"startTime":"0","endTime":"0","summary":"INVO BioScience press release  : Q4 Revenue of $1.38M   misses by $0.55M.Net loss was $(2.0) million, compared to $(2.8) million.Adjusted EBITDA was $(1.2) million, including transaction costs related to the potential merger, compared to $(2.2) million in the prior year.More on INVO BioScience  NAYA Biosciences to buy gene therapy company Florida Biotechnologies Seeking Alpha’s Quant Rating on INVO BioScience Historical earnings data for INVO BioScience Financial information for INVO BioScience","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4090281-invo-bioscience-reports-q4-results","is_publish_highlight":false,"gpt_icon":0},{"id":"2428388202","title":"INVO Bioscience Q4 Sales $1.38M Up From $278.14K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2428388202","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2428388202?lang=en_us&edition=fundamental","pubTime":"2024-04-17 05:02","pubTimestamp":1713301326,"startTime":"0","endTime":"0","summary":"INVO Bioscience (NASDAQ:INVO) reported $1.38 million in sales this quarter. This is a 396.15 percent increase over sales of $278.14 thousand the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/04/38281707/invo-bioscience-q4-sales-1-38m-up-from-278-14k-yoy","is_publish_highlight":false,"gpt_icon":0},{"id":"2428388242","title":"Press Release: INVO Reports Fourth Quarter and Full Year 2023 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2428388242","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2428388242?lang=en_us&edition=fundamental","pubTime":"2024-04-17 04:59","pubTimestamp":1713301140,"startTime":"0","endTime":"0","summary":"SARASOTA, Fla., April 16, 2024  -- INVO Bioscience, Inc.  , a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and with the intravaginal culture  procedure enabled by its INVOcell medical device, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023 and provided a business update.-- Revenue was $1,381,754, an increase of 397% compared to $278,142.-- Clinic revenue increased 519% to $1,362,938, compared to $220,253. All. reported clinic revenue is derived from the Company's INVO Center in. Atlanta, Georgia, and fertility clinic in Madison, Wisconsin which are. -- Revenue from all clinics, inclusive of both those accounted for as. consolidated and under the equity method, was $1,634,912, an increase of. -- Total operating expenses were $2.9 million, a $0.1 million decrease. NAYA Biosciences, Inc.  to acquire NAYA in an all-stock. \"We ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2405170461","title":"INVO BioScience Shares Up 5% as NAYA Agrees to Buy Florida Biotechnologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2405170461","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2405170461?lang=en_us&edition=fundamental","pubTime":"2024-01-24 01:58","pubTimestamp":1706032680,"startTime":"0","endTime":"0","summary":"Shares of INVO BioScience, which is merging with NAYA Biosciences, rose 5% Tuesday after NAYA entered a binding term sheet to buy gene therapy company Florida Biotechnologies.The stock was recently at $1.08 and is down about 90% over the past 52 weeks.The Florida Biotechnologies deal is contingent on the closing of the INVO transaction and is valued at $20 million of NAYA stock post-merger, plus up to $5 million of stock for milestones.INVO, which provides the INVOcell fertility treatment, said last week that it filed S-4 registration and preliminary joint proxy statements in connection with the NAYA merger.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2405129725","title":"BUZZ-INVO rises as partner NAYA to acquire gene therapy company","url":"https://stock-news.laohu8.com/highlight/detail?id=2405129725","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2405129725?lang=en_us&edition=fundamental","pubTime":"2024-01-23 21:47","pubTimestamp":1706017620,"startTime":"0","endTime":"0","summary":"** Medical device maker INVO Bioscience's    shares rise 8.7% to $1.12 premarket   ** Company says partner NAYA Biosciences will acquire Florida Biotechnologies, a gene therapy company focusing on treatment of mitochondrial diseases   ** INVO says Florida Biotechnologies' gene therapy program has received more than $6 mln in grant funding and qualifies for U.S. FDA's Regenerative Medicine Advanced Therapy  designation and multiple priority FDA review vouchers   ** RMAT designation expedites development and review of regenerative medicine therapies and offers sponsor companies early interactions with FDA   ** As of last close, stock down 90.3% in past 12 months ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2405124196","title":"NAYA Biosciences to buy gene therapy company Florida Biotechnologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2405124196","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2405124196?lang=en_us&edition=fundamental","pubTime":"2024-01-23 21:14","pubTimestamp":1706015656,"startTime":"0","endTime":"0","summary":"NAYA Biosciences entered into a binding letter of intent to buy Florida Biotechnologies Inc, a gene therapy company focusing on the treatment of mitochondrial diseases. NAYA entered into a binding term sheet with Florida Biotechnologies Inc to buy all of the outstanding capital stock of Florida Biotechnologies for $20M in shares of NAYA post-merger with INVO, or 4M shares, each worth $5.00.  Florida Biotechnologies is eligible for an additional $5M or 1M shares each worth $5.00, upon achievement of certain milestones. The Florida Biotechnologies deal is contingent on the closing of the INVO merger and sufficient financing to further develop the gene therapy programs from Florida Biotechnologies. In conjunction with this transaction, Peter Kash will join NAYA’s board of directors as Vice Chairman. NAYA expects to close its previously announced merger with INVO Bioscience  in Q1 2024 following the recent filing of S-4 and joint draft proxy statements. Source: Press Release    More on INV","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4057303-naya-biosciences-to-buy-gene-therapy-company-florida-biotechnologies","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.invobio.com","stockEarnings":[{"period":"1week","weight":-0.2385},{"period":"1month","weight":-0.3219},{"period":"3month","weight":-0.0117},{"period":"6month","weight":-0.4978},{"period":"1year","weight":-0.8798},{"period":"ytd","weight":-0.3119}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0705},{"period":"3month","weight":0.067},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.1152}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. INVO Bioscience, Inc. was founded in 2007 and is based in Sarasota, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":0.082525},{"month":2,"riseRate":0.5,"avgChangeRate":0.003556},{"month":3,"riseRate":0.5,"avgChangeRate":0.076047},{"month":4,"riseRate":0,"avgChangeRate":-0.230873},{"month":5,"riseRate":0.2,"avgChangeRate":-0.182553},{"month":6,"riseRate":0.5,"avgChangeRate":-0.02379},{"month":7,"riseRate":0.75,"avgChangeRate":0.208581},{"month":8,"riseRate":0,"avgChangeRate":-0.211935},{"month":9,"riseRate":0.25,"avgChangeRate":-0.165701},{"month":10,"riseRate":0.75,"avgChangeRate":0.179933},{"month":11,"riseRate":0.25,"avgChangeRate":-0.054283},{"month":12,"riseRate":0.25,"avgChangeRate":-0.20874}],"exchange":"NASDAQ","name":"INVO BioScience, Inc.","nameEN":"INVO BioScience, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INVO BioScience, Inc.(INVO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INVO BioScience, Inc.(INVO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INVO BioScience, Inc.,INVO,INVO BioScience, Inc.股票,INVO BioScience, Inc.股票老虎,INVO BioScience, Inc.股票老虎国际,INVO BioScience, Inc.行情,INVO BioScience, Inc.股票行情,INVO BioScience, Inc.股价,INVO BioScience, Inc.股市,INVO BioScience, Inc.股票价格,INVO BioScience, Inc.股票交易,INVO BioScience, Inc.股票购买,INVO BioScience, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INVO BioScience, Inc.(INVO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INVO BioScience, Inc.(INVO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction